This article was previously published June 4, 2020, and has been updated with new information. The recent coronavirus pandemic has infected over 5 million people and has caused over 300,000 deaths. This pandemic has also caused school and business closings, social distancing, and has forced millions of people to be confined to their homes. Social… Read More »
Women are twice as likely as men to suffer from a depressive disorder. In addition, they are vulnerable to mood disorders associated with reproductive functioning, specifically premenstrual dysphoric disorder, perinatal depression, and perimenopausal depression. There is strong evidence to indicate that biological factors (genetic vulnerability, hormonal changes) and psychosocial factors (life stress) interact with one… Read More »
In 2019, the Food and Drug Administration (FDA) approved brexanolone, marketed by Sage Therapeutics as Zulresso, as a treatment for postpartum depression (PPD). As a neurosteroid, brexanolone represents a novel approach to the treatment of postpartum mood disorders. One of the most exciting things about brexanolone is the rapidity of the response, with the initial… Read More »
Previous studies have observed that the children of depressed mothers are more likely to have delays in cognitive development, worse school performance, higher rates of behavioral problems, and deficits in social-emotional regulation. Children of depressed mothers are also more likely to experience adolescent depression. Most studies have understood these vulnerabilities to neurodevelopmental problems and psychiatric… Read More »
Postpartum depression (PPD) is a relatively common problem, affecting between 10% and 15% of women after delivery. Although it is difficult to reliably predict which women in the general population will experience postpartum depression, it is possible to identify certain subgroups of women who are at increased risk for postpartum affective illness. For example, women… Read More »
A prototype from Project Amber of an EEG headset. Alphabet Alphabet‘s experimental research group, X, has been quietly working on an experimental project to monitor symptoms of depression. A blog post published on Monday details how a team of neuroscientists, hardware and software engineers and product experts have been working on a series of prototypes… Read More »
Severe morning sickness increases the risk of depression both during and after pregnancy, new research has found. Severe morning sickness, known as hyperemesis gravidarum (HG), is a debilitating condition that affects around 1-2 per cent of pregnant women in the UK. Far more serious than ‘normal’ morning sickness, it is one of the most common… Read More »